Flotek Announces First Quarter 2019 Results

HOUSTON, May 8, 2019 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE: FTK) today announced results for the three months ended March 31, 2019. As the results of the Company's Consumer and Industrial Chemistry Technologies ("CICT") segment are presented as discontinued operations for all periods, the financial discussion and comparisons substantially relate to Flotek's continuing operations.

First Quarter Highlights

    --  Announced on January 11, 2019, a $175 million all-cash transaction (the
        "Transaction") for the sale of Florida Chemical Company, LLC ("FCC") to
        Archer-Daniels-Midland Company ("ADM").
    --  Closed the Transaction effective February 28, 2019, with Flotek
        receiving net proceeds of approximately $111 million, after related
        transaction fees, a working capital adjustment, and repayment of the
        remaining $54 million balance of the Company's credit facility. Net
        proceeds are subject to customary post-closing working capital and other
        adjustments.
    --  Formed the Strategic Capital Committee, co-chaired by independent
        director, David Nierenberg, and Flotek's Chief Financial Officer,
        Elizabeth Wilkinson, which will provide recommendations to Flotek's
        Board of Directors as to the best use of remaining net proceeds from the
        Transaction.
    --  Leveraged the Company's full-service wellsite delivery offering in major
        domestic basins to drive increased customer adoption of Flotek's
        Prescriptive Chemistry Management(®) ("PCM(®)") platform.
    --  Continued to execute on the Company's previously announced strategic
        initiatives to further optimize the cost structure across the business
        and drive greater profitability through manufacturing and logistics
        efficiencies.

Financial Summary

    --  Significantly improved its financial position during the first quarter
        of 2019. As of March 31, 2019, the Company had cash and equivalents of
        $96.8 million, plus $17.5 million in temporarily escrowed funds related
        to the Transaction and no outstanding debt. This is compared to cash and
        equivalents of $3.0 million and debt of $49.7 million as of December 31,
        2018.
    --  Generated revenue of $43.3 million, as compared to $43.4 million for the
        fourth quarter of 2018 and $41.1 million for the first quarter of 2018.
    --  Reported a loss from continuing operations of $15.4 million, or $0.26
        loss per diluted share, versus income of $9.9 million, or $0.17 per
        diluted share, for the fourth quarter of 2018 and a loss of $9.5
        million, or $0.17 loss per diluted share, for the first quarter of 2018.
    --  Reported an adjusted loss from continuing operations of $11.6 million,
        or $0.20 loss per diluted share, as compared to an adjusted loss of $6.5
        million, or $0.11 loss per diluted share, for the fourth quarter of 2018
        and an adjusted loss of $8.6 million, or $0.15 loss per diluted share,
        for the first quarter of 2018.
    --  Adjusted earnings before interest, taxes, depreciation and amortization
        ("Adjusted EBITDA"), was a loss of $8.3 million, versus a loss of $5.9
        million for the fourth quarter of 2018 and a loss of $4.1 million for
        the first quarter of 2018.

Adjusted EBITDA and Adjusted Income from Continuing Operations are Non-GAAP financial measures and are described and reconciled to the closest GAAP measure in the attached tables at the end of this release.

John Chisholm, Flotek's Chairman, President and Chief Executive Officer, commented, "The macro-environment for U.S. onshore drilling and completions activity during the first quarter continued to be volatile, and a similar backdrop is expected for the second quarter. Given this environment, we were pleased our top-line results for the first quarter held steady with the fourth quarter of 2018. Contributing to our results was continued traction in the market for our full-service PCM(®) wellsite delivery offering with the majority of our sales now marketed directly to the operator.

"The most significant highlight of the first quarter was our sale of Florida Chemical to ADM, and we look forward to working closely with ADM as we jointly explore and develop next generation technologies for the oil and gas and agricultural industries. As important, the sale of Florida Chemical provides Flotek with substantial financial flexibility as we focus on prudently growing our position as a pure-play provider of customized, performance-enhancing chemistry solutions to the upstream oil and gas industry."

First Quarter 2019 Financial Results

For the three months ended March 31, 2019, Flotek reported revenue of $43.3 million, an increase of $2.2 million, or 5.3%, from the same period in 2018. First quarter 2019 revenue was relatively flat with revenue of $43.4 million for the fourth quarter of 2018.

Flotek reported a loss from continuing operations for the three months ended March 31, 2019 of $15.4 million, or $0.26 loss per diluted share, as compared to a loss of $9.5 million, or $0.17 loss per diluted share, in the same period of 2018 and income from continuing operations of $9.9 million, or $0.17 per diluted share, for the fourth quarter of 2018. The fourth quarter included a $22.7 million tax benefit primarily associated with the reversal of a valuation allowance against Flotek's deferred tax assets due to the anticipated sale of FCC.

Adjusted earnings from continuing operations was a loss of $11.6 million, or $0.20 loss per diluted share, for the three months ended March 31, 2019, as compared to a loss of $8.6 million, or $0.15 loss per diluted share, in the same period of 2018 and a loss of $6.5 million, or $0.11 loss per diluted share, for the fourth quarter of 2018. (See the Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings at the conclusion of this release.)

Earnings Before Interest, Taxes, Depreciation and Amortization ("EBITDA") for the three months ended March 31, 2019, was a loss of $12.1 million, as compared to loss of $7.2 million for the same period in 2018 and a loss of $9.6 million for the fourth quarter of 2018. (See the Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings at the conclusion of this release.)

Adjusted EBITDA for the three months ended March 31, 2019 was a loss of $8.3 million, as compared to a loss of $4.1 million for the same period in 2018 and a loss of $5.9 million for the fourth quarter of 2018.

    --  The increased year-over-year loss was primarily due to higher logistics
        expenses, tighter product margins and the write-down of certain customer
        receivables in the first quarter 2019, partially offset by lower
        corporate general and administrative and research and development
        expenses.
    --  Contributing to the higher loss from the fourth quarter of 2018 were
        tighter product margins and a bonus accrual reversal taken in the fourth
        quarter, as well as the write-off of a software license no longer
        required and a net increase in the write-down of certain customer
        receivables in the first quarter 2019. Partially offsetting the
        increased loss were lower logistics expenses in the first quarter 2019.

Management believes that adjusted EBITDA provides useful information to investors to better assess and understand operating performance and cash flows. (See the Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings at the conclusion of this release.)

Balance Sheet and Liquidity

As of March 31, 2019, the Company had cash and equivalents of $96.8 million, plus $17.5 million in escrowed funds related to the sale of FCC and no debt outstanding. Net debt at December 31, 2018, was $46.7 million, including $3.0 million in cash and $49.7 million of borrowings on the Company's credit facility.

In conjunction with closing the Transaction effective February 28, 2019, the Company paid down the entirety of its credit facility borrowings, which totaled $53.8 million and is expected to save nearly $3 million in annual interest expense from year-end 2018 levels.

Outlook

Mr. Chisholm concluded, "We remain laser-focused on managing our business to sustained long-term profitability in a $50 to $60 per barrel WTI price environment. In the course of transitioning Flotek from a business with four segments down to one, significant cost optimization efforts have continued into 2019 and we look forward to seeing the benefits of these top-to-bottom initiatives in the second half of the year. These efforts include an ongoing push to drive increased operational efficiencies and overall margin improvement, which will be more fully reflected in our results as we further grow market share due to our best-in-class suite of custom chemistry solutions optimized for the reservoir. I am also pleased by the important progress made to date by our Strategic Capital Committee. We view the effective deployment of the substantial net proceeds from the sale of FCC as extremely critical to the Company's long-term success, and believe the Committee's thoughtful, methodical and detailed process will result in a strategy that drives the most value for our shareholders.

"Oil and gas operators continue to seek opportunities to structurally improve costs by de-coupling the supply chain, and we expect this trend to accelerate moving forward as it relates to chemicals. While this has created a period of turbulence in the near term, we believe the end result will be increased operational predictability. We believe we are well positioned for long-term success given our industry-leading focus on reservoir-centric fluid systems that enhance and improve performance, which provides oil and gas operators greater transparency, control and efficacy in their fluid systems. Our differentiated PCM(®) platform and broad portfolio of value-added chemistries is becoming even more recognized by clients as truly innovative and effective solutions for markedly increasing the amount of hydrocarbons recovered from the reservoir, which lowers their cost per BOE and improves their return on capital. We will continue to closely partner with our clients to ensure they clearly understand the long-term value proposition of our unique product offerings."

Conference Call Details

Flotek will host a conference call on Thursday, May 9, at 9:00 AM CT (10:00 AM ET) to discuss its operating results for the three months ended March 31, 2019. To participate in the call, participants should dial 844-835-9986 approximately 5 minutes prior to the start of the call. The call can also be accessed from Flotek's website at www.flotekind.com.

About Flotek Industries, Inc.

Flotek develops and delivers prescriptive, reservoir-centric chemistry technologies to oil and gas clients designed to address every challenge in the lifecycle of the reservoir and maximize recovery in both new and mature fields. Flotek's inspired chemists draw from the power of bio-derived solvents to deliver solutions that enhance energy production. Flotek serves major and independent energy producers and oilfield service companies, both domestic and international. Flotek Industries, Inc. is a publicly traded company headquartered in Houston, Texas, and its common shares are traded on the New York Stock Exchange under the ticker symbol "FTK." For additional information, please visit Flotek's web site at www.flotekind.com.

Forward-Looking Statements

Certain statements set forth in this Press Release constitute forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934) regarding Flotek Industries, Inc.'s business, financial condition, results of operations and prospects. Words such as expects, anticipates, intends, plans, believes, seeks, estimates and similar expressions or variations of such words are intended to identify forward-looking statements, but are not the exclusive means of identifying forward-looking statements in this Press Release.

Although forward-looking statements in this Press Release reflect the good faith judgment of management, such statements can only be based on facts and factors currently known to management. Consequently, forward-looking statements are inherently subject to risks and uncertainties, and actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. Factors that could cause or contribute to such differences in results and outcomes include, but are not limited to, demand for oil and natural gas drilling services in the areas and markets in which the Company operates, competition, obsolescence of products and services, the Company's ability to obtain financing to support its operations, environmental and other casualty risks, and the impact of government regulation.

Further information about the risks and uncertainties that may impact the Company are set forth in the Company's most recent filings on Form 10-K (including without limitation in the "Risk Factors" Section), and in the Company's other SEC filings and publicly available documents. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this Press Release. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this Press Release.


                                                      
            
              Flotek Industries, Inc.


                                          
            
              Unaudited Condensed Consolidated Balance Sheets


                                                 
            
              (in thousands, except share data)




                                                       
            
              March 31, 2019                     
     
     December 31, 2018

                                                                                                                                     ---

                               
            
              ASSETS



     Current assets:


      Cash and cash equivalents                                                        $96,753                                     $3,044



     Restricted cash                                                                      660                                          -


      Accounts receivable, net of allowance for doubtful accounts of $1,465 and
       $1,190 at March 31, 2019 and December 31, 2018, respectively

                                                                                        37,178                                     37,047



     Inventories, net                                                                  34,358                                     27,289



     Income taxes receivable                                                            3,351                                      3,161



     Assets held for sale                                                                   -                                   118,470



     Other current assets                                                              20,373                                      5,771




     Total current assets                                                             192,673                                    194,782


      Property and equipment, net                                                       42,989                                     45,485


      Operating lease right-of-use
       assets                                                                           18,202                                          -



     Deferred tax assets, net                                                             599                                     18,663


      Other intangible assets, net                                                      24,978                                     26,827



     Other long-term assets                                                             3,351                                        126




     
              TOTAL ASSETS                                                         $282,792                                   $285,883

                                                                                                                                     ===

                
            
              LIABILITIES AND STOCKHOLDERS' EQUITY



     Current liabilities:



     Accounts payable                                                                 $13,798                                    $15,011



     Accrued liabilities                                                               12,518                                     10,335



     Income taxes payable                                                               2,054                                          -



     Interest payable                                                                       -                                         8


      Liabilities held for sale                                                              -                                     9,174


      Current portion of lease
       liabilities                                                                         713                                          -


      Long-term debt, classified as
       current                                                                               -                                    49,731



      Total current liabilities                                                         29,083                                     84,259


      Operating lease liabilities                                                       18,416                                          -


      Finance lease liabilities                                                            130                                          -


      Deferred tax liabilities, net                                                        116                                          -



     Total liabilities                                                                 47,745                                     84,259




     Commitments and contingencies



     Stockholders' equity:


      Preferred stock, $0.0001 par value, 100,000 shares authorized; no shares
       issued and outstanding

                                                                                             -


      Common stock, $0.0001 par value, 80,000,000 shares authorized; 62,198,912
       shares issued and 57,462,355 shares outstanding at March 31, 2019; 62,162,875
       shares issued and 57,342,279 shares outstanding at December 31, 2018

                                                                                             6                                          6


      Additional paid-in capital                                                       344,004                                    343,536


      Accumulated other comprehensive
       income (loss)                                                                   (1,022)                                   (1,116)


      Retained earnings (accumulated
       deficit)                                                                       (74,573)                                 (107,565)


      Treasury stock, at cost; 3,845,173 and 3,770,224 shares at March 31, 2019 and
       December 31, 2018, respectively

                                                                                      (33,368)                                  (33,237)

                                                                                                                                     ---

      Total stockholders' equity                                                       235,047                                    201,624



                 TOTAL LIABILITIES AND
                  STOCKHOLDERS' EQUITY                                                $282,792                                   $285,883

                                                                                                                                     ===


                                                            
             
                Flotek Industries, Inc.


                                           
              
               Unaudited Condensed Consolidated Statements of Operations


                                                     
              
               (in thousands, except per share data)




                                                    
              
               Three Months Ended





                                                                           3/31/2019                                       3/31/2018  12/31/2018

                                                                                                                                             ---



                   Revenue                                                   $43,256                                          $41,069      $43,449



     
                Costs and expenses:


      Cost of revenue (excluding
       depreciation and
       amortization)                                                          44,599                                           36,655       41,963


      Corporate general and
       administrative                                                          7,281                                            8,493        6,833


      Depreciation and amortization                                            2,260                                            2,333        2,282


      Research and development                                                 2,285                                            2,754        2,302


      Loss (gain) on disposal of
       long-lived assets                                                       1,097                                               57        (563)


      Total costs and expenses                                                57,522                                           50,292       52,817



                   Loss from operations                                     (14,266)                                         (9,223)     (9,368)



     
                Other (expense) income:



     Interest expense                                                       (1,998)                                           (516)       (964)


      Other income (expense), net                                                110                                            (111)     (2,441)



      Total other expense                                                    (1,888)                                           (627)     (3,405)



                   Loss before income taxes                                 (16,154)                                         (9,850)    (12,773)



     Income tax benefit                                                         774                                              322       22,716



                   (Loss) income from continuing
                    operations                                              (15,380)                                         (9,528)       9,943


                   Income (loss) from
                    discontinued operations, net
                    of tax                                                    48,372                                            9,595      (1,385)


                   Net income                                                 32,992                                               67        8,558


                   Net loss attributable to
                    noncontrolling interests                                       -                                                           1


                   Net income attributable to
                    Flotek Industries, Inc.
                    (Flotek)                                                 $32,992                                              $67       $8,559

                                                                                                                                             ===



                   Amounts attributable to Flotek shareholders:


      Loss from continuing
       operations                                                          $(15,380)                                        $(9,528)      $9,944


      Income (loss) from
       discontinued operations, net
       of tax                                                                 48,372                                            9,595      (1,385)


      Net income attributable to
       Flotek                                                                $32,992                                              $67       $8,559

                                                                                                                                             ===

                   Basic earnings (loss) per common share:


      Continuing operations                                                  $(0.26)                                         $(0.17)       $0.17


      Discontinued operations, net
       of tax                                                                   0.83                                             0.17       (0.02)


      Basic earnings (loss) per
       common share                                                            $0.57                      
              $              -       $0.15

                                                                                                                                             ===

                   Diluted earnings (loss) per common share:


      Continuing operations                                                  $(0.26)                                         $(0.17)       $0.17


      Discontinued operations, net
       of tax                                                                   0.83                                             0.17       (0.02)


      Diluted earnings (loss) per
       common share                                                            $0.57                      
              $              -       $0.15

                                                                                                                                             ===


     
                Weighted average common shares:


      Weighted average common
       shares used in computing
       basic earnings (loss) per
       common share                                                           58,373                                           57,259       58,517


      Weighted average common
       shares used in computing
       diluted earnings (loss) per
       common share                                                           58,373                                           57,259       58,517


                                            
              
                Flotek Industries, Inc.


                           
              
                Unaudited Condensed Consolidated Statements of Cash Flows


                                                 
              
                (in thousands)


                                                                               Twelve Months Ended



                                                                                         3/31/2019           3/31/2018

                                                                                                                   ---


     
                Cash flows from operating activities:



     Net income                                                                           $32,992                  $67


      Income from discontinued
       operations, net of tax                                                               48,372                9,595



      Loss from continuing operations                                                     (15,380)             (9,528)


      Adjustments to reconcile loss from continuing operations to net
       cash used in operating activities:


      Depreciation and amortization                                                          2,260                2,333


      Amortization of deferred financing
       costs                                                                                 1,428                   96


      Provision for doubtful accounts                                                          366                 (43)


      Provision for excess and obsolete
       inventory                                                                                 -               1,305



     Loss on sale of assets                                                                 1,097                   57



     Non-cash lease expense                                                                   230                    -


      Stock compensation expense                                                               456                1,899


      Deferred income tax provision
       (benefit)                                                                            17,860              (7,662)


      Reduction in tax benefit related
       to share-based awards                                                                    24                    3



     Changes in current assets and liabilities:



     Restricted cash                                                                        (660)                   -


      Accounts receivable, net                                                               (474)               1,715



     Inventories, net                                                                     (7,031)               5,729



     Income taxes receivable                                                                (247)                 (1)



     Other current assets                                                                (18,661)                 331



     Accounts payable                                                                     (1,216)               (781)



     Accrued liabilities                                                                  (8,193)             (7,599)



     Income taxes payable                                                                   2,428                    -



     Interest payable                                                                         (8)                (37)


      Net cash used in operating
       activities                                                                         (25,721)            (12,183)




     
                Cash flows from investing activities:



     Capital expenditures                                                                   (461)             (1,377)


      Proceeds from sales of businesses                                                    169,722                    -


      Proceeds from sale of assets                                                             132                   80


      Purchase of patents and other
       intangible assets                                                                     (103)               (117)


      Net cash provided by (used in)
       investing activities                                                                169,290              (1,414)




     
                Cash flows from financing activities:


      Borrowings on revolving credit
       facility                                                                             42,984               76,266


      Repayments on revolving credit
       facility                                                                           (92,715)            (64,475)



     Debt issuance costs                                                                        -                 (8)


      Purchase of treasury stock related
       to share-based awards                                                                 (131)                 (3)


      Proceeds from sale of common stock                                                         -                 146


      Net cash (used in) provided by
       financing activities                                                               (49,862)              11,926




     
                Discontinued operations:


      Net cash (used in) provided by
       operating activities                                                                  (337)                 430


      Net cash provided by (used in)
       investing activities                                                                    337                (430)


      Net cash flows provided by
       discontinued operations                                                                   -

                                                                                                                   ---

      Effect of changes in exchange
       rates on cash and cash
       equivalents                                                                               2                 (48)



                   Net increase (decrease) in cash
                    and cash equivalents                                                    93,709              (1,719)


      Cash and cash equivalents at the
       beginning of period                                                                   3,044                4,584



                   Cash and cash equivalents at the
                    end of period                                                          $96,753               $2,865

                                                                                                                   ===


                                         
              
                Flotek Industries, Inc.


            
              
                Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings


                                  
              
                (in thousands, except per share data)




                                    GAAP Income (Loss) from Continuing Operations and Reconciliation to Adjusted Net Income (Loss) (Non-GAAP)

                                                               ---



                                                                                   Three Months Ended



                                                                  
              3/31/2019                      
              3/31/2018               
     12/31/2018







                     Income (Loss) from Continuing
                      Operations (GAAP)                                      $(15,380)                                  $(9,528)                     $9,944




                     Deferred Tax Asset Valuation
                      Allowance                                                                                                                      (18,924)




                     Select Items Impacting Earnings, net
                      of tax                                                       3,760                                        909                       2,522




                     Adjusted Net Income (Loss) (Non-
                      GAAP)                                                  $(11,620)                                  $(8,619)                   $(6,458)

                                                                                                                                                        ===



                     Weighted Average Shares
                      Outstanding (Fully Diluted)                               58,373                                     57,259                      58,517




                     Adjusted Earnings (Loss) Per
                      Share (Fully Diluted)                                    $(0.20)                                   $(0.15)                    $(0.11)

                                                                                                                                                        ===



                                    Select Items Impacting Earnings

    ---



          
              Severance and Retirement                                      1,721                                         94                       1,810




                     Shareholder-Related Activities                                  581




          
              Inventory Write-down                                                                                    1,000




          
              Deferred Financing Costs                                      1,360




                     Loss (Gain) on Disposal of Assets                             1,097                                         57                       (563)




                     Discontinuation of Corporate Projects                                                                                              1,945




                     Total Select Items                                         $4,759                                     $1,151                      $3,192

                                                                                                                                                        ===



                     Less income tax effect (21%)                                 (999)                                     (242)                      (670)




                     Select Items Impacting Earnings, net
                      of tax                                                      $3,760                                       $909                      $2,522





        * Management believes that adjusted Net Income for the three months ended March 31, 2019, March 31, 2018, and December 31, 2018, is
         useful to investors to assess and understand operating performance, especially when comparing those results with previous and
         subsequent periods. Management views the expenses noted above to be outside of the Company's normal operating results. Management
         analyzes operating results without the impact of the above items as an indicator of performance, to identify underlying trends in the
         business and cash flow from continuing operations, and to establish operational goals.


                                                   
              
                Flotek Industries, Inc.


                      
              
                Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings


                                                       
              
                (in thousands)





       
     
                  GAAP Income (Loss) from Continuing Operations and Reconciliation to Adjusted EBITDA (Non-GAAP)

    ---



                                                                                                                                Three Months Ended



                                                                       
              3/31/2019                
              3/31/2018                    
     12/31/2018







          Income (Loss) from Continuing
           Operations (GAAP)                                                      $(15,380)                            $(9,528)                          $9,944




                                           
              Interest Expense                             1,998                               516                             964




                                           
              Interest Income                              (226)                            (183)                           (45)




                                           
              Income Tax Benefit                           (774)                            (322)                       (22,716)




                                                      Depreciation and Amortization                2,260                             2,333                           2,282




          EBITDA (Non-GAAP)                                                       $(12,122)                            $(7,184)                        $(9,571)





                                           
              Stock Compensation Expense                     456                             1,900                             480




                                           
              Severance and Retirement                     1,721                                94                           1,810




                                                      Shareholder-Related Activities                 581                                                                -




                                           
              Inventory Write-down                                                          1,000                               -




                                                      Loss (Gain) on Disposal of Assets            1,097                                57                           (563)




                                                      Discontinuation of Corporate Projects                                                                        1,945




          Adjusted EBITDA (Non-GAAP)                                               $(8,267)                            $(4,133)                        $(5,899)



               * Management believes that
                adjusted EBITDA for the three
                and twelve months ended March
                31, 2019, March 31, 2018, and
                December 31, 2018, is useful to
                investors to assess and
                understand operating
                performance, especially when
                comparing those results with
                previous and subsequent periods.
                Management views the expenses
                noted above to be outside of the
                Company's normal operating
                results. Management analyzes
                operating results without the
                impact of the above items as an
                indicator of performance, to
                identify underlying trends in
                the business and cash flow from
                continuing operations, and to
                establish operational goals.

View original content to download multimedia:http://www.prnewswire.com/news-releases/flotek-announces-first-quarter-2019-results-300846958.html

SOURCE Flotek Industries, Inc.